Eli Lilly and Company
(India) Pvt. Ltd is a subsidiary of the US pharmaceutical
major, Eli Lilly and Company.
The company was set up in 1993 as a 50:50 joint venture between
Eli Lilly and the Indian partner Ranbaxy Laboratories Ltd.,
as Eli Lilly Ranbaxy Ltd. The venture was started primarily
to manufacture and market a select range of drugs of Eli Lilly
and Company. After its inception in 1993, the Indian operation
achieved a quick break-even in 1996. In August 2001, Eli Lilly
and Company acquired the 50% stake from Ranbaxy Laboratories
Ltd. to create a 100% Lilly subsidiary, Eli Lilly and Company
(India) Pvt. Ltd.
Lilly India’s growth curve has been phenomenal - revenues
surged from a modest Rs. 8 crores in 1994 to more than Rs.
150 crores in 2003. This achievement reflects in its ranking
among the top 50 pharmaceutical companies in India. Today,
Lilly India is among the fastest growing pharmaceutical companies
in the country.
|